Found: 25
Select item for more details and to access through your institution.
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Ultra‐performance liquid chromatography‐tandem mass spectrometry method for analysis of tau in human cerebrospinal fluid without the need of immunocapture: Biomarkers (non‐neuroimaging) / Method development and/or quality control.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040373
- By:
- Publication type:
- Article
Web‐based requisitioning, tracking and laboratory result reporting system for clinical trials using a central laboratory: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038627
- By:
- Publication type:
- Article
P1‐265: STANDARDIZATION OF AMYLOID BETA 42 IN‐HOUSE CALIBRATORS FOR A REFERENCE LC‐MS‐MS METHOD FOR ANALYSIS OF AMYLOID BETA 42 IN HUMAN CSF, USING THREE AVAILABLE CERTIFIED REFERENCE MATERIALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P341, doi. 10.1016/j.jalz.2019.06.820
- By:
- Publication type:
- Article
P2‐091: ASSAY PERFORMANCE MONITORING FOR AD BIOMARKERS USING POOLED CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P702, doi. 10.1016/j.jalz.2018.06.776
- By:
- Publication type:
- Article
P1‐255: ANALYTICAL AND CLINICAL PERFORMANCE OF AMYLOID BETA PEPTIDES: MEASUREMENT IN CSF OF ADNI2 AND GO PARTICIPANTS BY A LC‐MS‐MS REFERENCE METHOD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P378, doi. 10.1016/j.jalz.2018.06.261
- By:
- Publication type:
- Article
PROGRESS ON THE DEVELOPMENT OF CERTIFIED REFERENCE MATERIALS FOR Aβ1-42.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1512, doi. 10.1016/j.jalz.2017.07.629
- By:
- Publication type:
- Article
DERIVING A CUT-OFF FOR THE ELECSYS® β-AMYLOID (1–42) IMMUNOASSAY FOR USE IN CLINICAL TRIALS SUPPORTED BY ELI LILLY FOR PATIENTS WITH CLINICALLY DEFINED ALZHEIMER’S DISEASE (AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1317, doi. 10.1016/j.jalz.2017.06.2022
- By:
- Publication type:
- Article
ESCITALOPRAM DECREASES LONGITUDINAL CSF ABETA CONCENTRATION IN COGNITIVELY NORMAL SUBJECTS AGE 60-85.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P199, doi. 10.1016/j.jalz.2016.06.349
- By:
- Publication type:
- Article
METHOD COMPARISON OF AB(1-42) MEASURED IN HUMAN CEREBROSPINAL FLUID SAMPLES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, THE INNO-BIA ALZBIO3 ASSAY, AND THE ELECSYS® B-AMYLOID(1-42) ASSAY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P668, doi. 10.1016/j.jalz.2016.06.1513
- By:
- Publication type:
- Article
Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, n. 1, p. 55, doi. 10.1016/j.jalz.2015.06.1890
- By:
- Publication type:
- Article
A candidate reference method for analysis of amyloid beta 1-42 (Aß1-42) peptide in human CSF using 2D-HPLC with a xevo t q-s mass spectrometer.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P349, doi. 10.1016/j.jalz.2015.06.229
- By:
- Publication type:
- Article
Prospective quality-control monitoring in the context of a clinical trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P386, doi. 10.1016/j.jalz.2015.06.317
- By:
- Publication type:
- Article
The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. 772, doi. 10.1016/j.jalz.2015.05.003
- By:
- Publication type:
- Article
International round robin on SRM triple quad mass spectrometric analysis of aβ42 in cerebrospinal fluid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P797, doi. 10.1016/j.jalz.2014.05.1555
- By:
- Publication type:
- Article
Ultra-performance 2D-liquid chromatography–tandem mass spectrometry method for simultaneous analysis of beta-amyloid peptides: 1-38, 1-40 and 1-42 in human cerebrospinal fluid
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 4, p. 250, doi. 10.1016/j.jalz.2012.01.001
- By:
- Publication type:
- Article
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2010, v. 6, n. 3, p. 230, doi. 10.1016/j.jalz.2010.03.008
- By:
- Publication type:
- Article
Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids.
- Published in:
- Journal of Neurochemistry, 2021, v. 159, n. 2, p. 211, doi. 10.1111/jnc.15465
- By:
- Publication type:
- Article
Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice.
- Published in:
- Journal of Applied Laboratory Medicine, 2020, p. 183, doi. 10.1373/jalm.2019.029587
- By:
- Publication type:
- Article
Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology.
- Published in:
- Clinical Chemistry, 2023, v. 69, n. 11, p. 1247, doi. 10.1093/clinchem/hvad139
- By:
- Publication type:
- Article
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC--MS/MS Reference Method.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 4, p. 587, doi. 10.1093/clinchem/hvaa012
- By:
- Publication type:
- Article
Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β<sub>1-42</sub> and τ Proteins as Alzheimer Disease Biomarkers.
- Published in:
- Clinical Chemistry, 2013, v. 59, n. 6, p. 903, doi. 10.1373/clinchem.2013.202937
- By:
- Publication type:
- Article
Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients with Delayed Graft Function.
- Published in:
- 1998
- By:
- Publication type:
- Other
The global Alzheimer's Association round robin study on plasma amyloid β methods.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12242
- By:
- Publication type:
- Article